Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of immune response to MenBVac in French children from Normandy
2011-006268-27Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of MenBvac in meningococcal disease, sponsored by Rouen University Hospital. Primary endpoint: hSBA level. Started Jan 2012; status: completed.
02
Drugs
MenBvac
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2011-006268-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006268-27.